RT Journal Article
SR Electronic
T1 Missed opportunities of flu vaccination in Italian target categories: insights from the online EPICOVID 19 survey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.30.20204560
DO 10.1101/2020.09.30.20204560
A1 Andrea Giacomelli
A1 Massimo Galli
A1 Stefania Maggi
A1 Gabriele Pagani
A1 Raffaele Antonelli Incalzi
A1 Claudio Pedone
A1 Mauro di Bari
A1 Marianna Noale
A1 Caterina Trevisan
A1 Fabrizio Bianchi
A1 Marcello Tavio
A1 Massimo Andreoni
A1 Claudio Mastroianni
A1 Aleksandra Sojic
A1 Federica Prinelli
A1 Fulvio Adorni
A1 on Behalf of EPICOVID19 Working Group
YR 2020
UL http://medrxiv.org/content/early/2020/09/30/2020.09.30.20204560.abstract
AB We aimed to assess the reported rate of flu vaccination in the season 2019/2020 in respondents to the Italian nationwide online EPICOVID 19 survey. A national convenience sample of volunteers aged 18 or older was assessed between 13th April and 2nd June 2020. Flu vaccine rates were calculated for all classes of age. The association between the independent variables and the flu vaccine was assessed by applying a multivariable binary logistic regression model. Of the 198,822 respondents 41,818 (21.0%) reported to have received a flu vaccination shot during the last influenza season. In particular, 15,009 (53.4%) subjects aged 65 years or older received a flu vaccination shot. Being 65 years aged or older (aOR 3.06, 95%CI 2.92-3.20) and having a high education level (aOR 1.34. 95%CI 1.28-1.41) were independently associated to flu vaccination. Heart and lung diseases were the morbidities associated with the higher odds of being vaccinated [aOR 1.97 (95%CI 1.86-2.09) and aOR 1.92 (95%CI 1.84-2.01), respectively]. Nursing home residents aged ≥ 65 years showed a lower odds of being vaccinated [aOR 0.39 (95%CI 0.28-0.54)]. Our data claims for an urgent public heath effort to fill the gap of missed vaccination opportunities reported in the past flu seasons.Competing Interest StatementThe authors have declared no competing interest.Funding StatementStudy not fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the National Institute for Infectious Diseases (Italian: Istituto Nazionale per le Malattie Infettive I.R.C.C.S. Lazzaro Spallanzani) approved the EPICOVID19 study protocol (Protocol No. 70, 12/4/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available upon reasonable request.